Knockdown CKS2 can inhibit cell proliferation, induce cell cycle arrest, and increase the expression of P53, P21 and PTEN, suggesting that CKS2 may be biomarkers of NSCLC [20]. The gene discussed is PTEN; the disease is non-small cell lung carcinoma.